These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2115 related items for PubMed ID: 28137967

  • 1. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH, Wu QY, Zheng R, Chen C, Chen Y, Liu Q, Hoffmann PR, Ni JZ, Song GL.
    J Neurosci; 2017 Mar 01; 37(9):2449-2462. PubMed ID: 28137967
    [Abstract] [Full Text] [Related]

  • 2. Selenomethionine Attenuates the Amyloid-β Level by Both Inhibiting Amyloid-β Production and Modulating Autophagy in Neuron-2a/AβPPswe Cells.
    Zhang ZH, Wu QY, Chen C, Zheng R, Chen Y, Liu Q, Ni JZ, Song GL.
    J Alzheimers Dis; 2017 Mar 01; 59(2):591-602. PubMed ID: 28671121
    [Abstract] [Full Text] [Related]

  • 3. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
    Song G, Zhang Z, Wen L, Chen C, Shi Q, Zhang Y, Ni J, Liu Q.
    J Alzheimers Dis; 2014 Mar 01; 41(1):85-99. PubMed ID: 24577479
    [Abstract] [Full Text] [Related]

  • 4. Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice.
    Hu Y, Lai J, Wan B, Liu X, Zhang Y, Zhang J, Sun D, Ruan G, Liu E, Liu GP, Chen C, Wang DW.
    Neurotoxicology; 2016 Mar 01; 53():290-300. PubMed ID: 26945731
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X, Kosaraju J, Zhou W, Tam KY.
    ACS Chem Neurosci; 2017 Mar 15; 8(3):676-685. PubMed ID: 28032988
    [Abstract] [Full Text] [Related]

  • 6. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012 Mar 15; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 7. Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance.
    Chen Y, Chen Y, Liang Y, Chen H, Ji X, Huang M.
    Biomed Pharmacother; 2020 Jan 15; 121():109670. PubMed ID: 31810131
    [Abstract] [Full Text] [Related]

  • 8. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF, Blanchard J, Dai CL, Tung YC, LaFerla FM, Iqbal IG, Iqbal K.
    Neurobiol Dis; 2014 Nov 15; 71():110-30. PubMed ID: 25046994
    [Abstract] [Full Text] [Related]

  • 9. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X, Kosaraju J, Zhou W, Tam KY.
    Neuropharmacology; 2018 Mar 15; 131():351-363. PubMed ID: 29309769
    [Abstract] [Full Text] [Related]

  • 10. Selenomethionine promoted hippocampal neurogenesis via the PI3K-Akt-GSK3β-Wnt pathway in a mouse model of Alzheimer's disease.
    Zheng R, Zhang ZH, Chen C, Chen Y, Jia SZ, Liu Q, Ni JZ, Song GL.
    Biochem Biophys Res Commun; 2017 Mar 25; 485(1):6-15. PubMed ID: 28109879
    [Abstract] [Full Text] [Related]

  • 11. Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons.
    Qin Y, Zhang Y, Tomic I, Hao W, Menger MD, Liu C, Fassbender K, Liu Y.
    J Alzheimers Dis; 2018 Mar 25; 65(1):243-263. PubMed ID: 30010136
    [Abstract] [Full Text] [Related]

  • 12. Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model.
    Long ZM, Zhao L, Jiang R, Wang KJ, Luo SF, Zheng M, Li XF, He GQ.
    CNS Neurosci Ther; 2015 Nov 25; 21(11):887-97. PubMed ID: 26385876
    [Abstract] [Full Text] [Related]

  • 13. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.
    J Alzheimers Dis; 2011 Nov 25; 24(3):421-54. PubMed ID: 21297257
    [Abstract] [Full Text] [Related]

  • 14. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E, Fujita H, Uchiyama N, Kori M, Takizawa M.
    J Neurochem; 2011 Dec 25; 119(6):1330-40. PubMed ID: 21992552
    [Abstract] [Full Text] [Related]

  • 15. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K, Prelli F, Mehta P, MacMurray C, Goñi F, Wisniewski T.
    Alzheimers Res Ther; 2018 Jun 18; 10(1):54. PubMed ID: 29914551
    [Abstract] [Full Text] [Related]

  • 16. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E, Granzotto A, Corona C, Bomba M, Ciavardelli D, Curcio M, Canzoniero LM, Navarra R, Lattanzio R, Piantelli M, Sensi SL.
    Neurobiol Dis; 2015 Sep 18; 81():214-24. PubMed ID: 25434488
    [Abstract] [Full Text] [Related]

  • 17. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.
    Sabogal-Guáqueta AM, Muñoz-Manco JI, Ramírez-Pineda JR, Lamprea-Rodriguez M, Osorio E, Cardona-Gómez GP.
    Neuropharmacology; 2015 Jun 18; 93():134-45. PubMed ID: 25666032
    [Abstract] [Full Text] [Related]

  • 18. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.
    Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM.
    J Neurosci; 2010 May 26; 30(21):7281-9. PubMed ID: 20505094
    [Abstract] [Full Text] [Related]

  • 19. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
    Shibuya Y, Niu Z, Bryleva EY, Harris BT, Murphy SR, Kheirollah A, Bowen ZD, Chang CCY, Chang TY.
    Neurobiol Aging; 2015 Jul 26; 36(7):2248-2259. PubMed ID: 25930235
    [Abstract] [Full Text] [Related]

  • 20. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT, Wang ZJ, Cai HY, Yuan L, Hu MM, Wu MN, Qi JS.
    Neurosci Bull; 2018 Oct 26; 34(5):736-746. PubMed ID: 30099679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 106.